British Journal of Cancer - Table of Contents alert Volume 110 Issue 10

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 110, Issue 10 (2389-2632) Published online 13 May 2014 In this issue Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics and Genomics Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Clinical Studies Top Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeks T Nomiya, H Tsuji, K Maruyama, S Toyama, H Suzuki, K Akakura, J Shimazaki, K Nemoto, T Kamada, H Tsujii and Working Group for Genitourinary Tumors Br J Cancer 2014 110: 2389-2395; advance online publication, April 10, 2014; 10.1038/bjc.2014.191 Abstract | Full Text Efficacy and toxicity of external-beam radiation therapy for localised prostate cancer: a network meta-analysis Z Zhu, J Zhang, Y Liu, M Chen, P Guo and K Li Br J Cancer 2014 110: 2396-2404; advance online publication, April 15, 2014; 10.1038/bjc.2014.197 Abstract | Full Text Identification of pathologically insignificant prostate cancer is not accurate in unscreened men G L Shaw, B C Thomas, S N Dawson, G Srivastava, S L Vowler, V J Gnanapragasam, N C Shah, A Y Warren and D E Neal Br J Cancer 2014 110: 2405-2411; advance online publication, April 10, 2014; 10.1038/bjc.2014.192 Abstract | Full Text Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom N B Gunsoy, M Garcia-Closas and S M Moss Br J Cancer 2014 110: 2412-2419; advance online publication, April 24, 2014; 10.1038/bjc.2014.206 Abstract | Full Text What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients C Rothermundt, J S Whelan, P Dileo, S J Strauss, J Coleman, T W Briggs, S R Haile and B M Seddon Br J Cancer 2014 110: 2420-2426; advance online publication, April 15, 2014; 10.1038/bjc.2014.200 Abstract | Full Text Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial D E Ediebah, C Coens, E Zikos, C Quinten, J Ringash, M T King, J Schmucker von Koch, C Gotay, E Greimel, H Flechtner, J Weis, B B Reeve, E F Smit, M J B Taphoorn and A Bottomley on behalf of the Lung Cancer Cooperative Group, Quality of Life Department and Patient Reported Outcome and Behavioural Evidence (PROBE) Group Br J Cancer 2014 110: 2427-2433; advance online publication, April 17, 2014; 10.1038/bjc.2014.208 Abstract | Full Text A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies C-C Lin, W-C Su, C-J Yen, C-H Hsu, W-P Su, K-H Yeh, Y-S Lu, A-L Cheng, D C-L Huang, H Fritsch, F Voss, T Taube and J C-H Yang Br J Cancer 2014 110: 2434-2440; advance online publication, April 22, 2014; 10.1038/bjc.2014.195 Abstract | Full Text Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours N A G Lankheet, J S L Kloth, C G M Gadellaa-van Hooijdonk, G A Cirkel, R H J Mathijssen, M P J K Lolkema, J H M Schellens, E E Voest, S Sleijfer, M J A de Jonge, J B A G Haanen, J H Beijnen, A D R Huitema and N Steeghs Br J Cancer 2014 110: 2441-2449; advance online publication, April 15, 2014; 10.1038/bjc.2014.194 Abstract | Full Text Translational Therapeutics Top HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer T M A Abdel-Fatah, S E B McArdle, C Johnson, P M Moseley, G R Ball, A G Pockley, I O Ellis, R C Rees and S Y T Chan Br J Cancer 2014 110: 2450-2461; advance online publication, April 22, 2014; 10.1038/bjc.2014.168 Abstract | Full Text Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer H-M Lin, L Castillo, K L Mahon, K Chiam, B Y Lee, Q Nguyen, M J Boyer, M R Stockler, N Pavlakis, G Marx, G Mallesara, H Gurney, S J Clark, A Swarbrick, R J Daly and L G Horvath Br J Cancer 2014 110: 2462-2471; advance online publication, April 8, 2014; 10.1038/bjc.2014.181 Abstract | Full Text Gemcitabine–oxaliplatin plus prednisolone is active in patients with castration-resistant prostate cancer for whom docetaxel-based chemotherapy failed J-L Lee, J-H Ahn, M K Choi, Y Kim, S-W Hong, K-H Lee, I-G Jeong, C Song, B-S Hong, J H Hong and H Ahn Br J Cancer 2014 110: 2472-2478; advance online publication, April 15, 2014; 10.1038/bjc.2014.204 Abstract | Full Text Multipoint targeting of the PI3K/mTOR pathway in mesothelioma S Zhou, L Liu, H Li, G Eilers, Y Kuang, S Shi, Z Yan, X Li, J M Corson, F Meng, H Zhou, Q Sheng, J A Fletcher and W-B Ou Br J Cancer 2014 110: 2479-2488; advance online publication, April 24, 2014; 10.1038/bjc.2014.220 Abstract | Full Text Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance A Azimi, M Pernemalm, M Frostvik Stolt, J Hansson, J Lehtiö, S Egyházi Brage and C Hertzman Johansson Br J Cancer 2014 110: 2489-2495; advance online publication, April 10, 2014; 10.1038/bjc.2014.169 Abstract | Full Text Molecular Diagnostics Top Potent anti-tumour activity of a novel conditionally replicating adenovirus for melanoma via inhibition of migration and invasion G Jiang, C-S Yang, D Xu, C Sun, J-N Zheng, T-C Lei and Y-Q Liu Br J Cancer 2014 110: 2496-2505; advance online publication, April 8, 2014; 10.1038/bjc.2014.177 Abstract | Full Text Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer M Toyoda, K Kaira, Y Ohshima, N S Ishioka, M Shino, K Sakakura, Y Takayasu, K Takahashi, H Tominaga, N Oriuchi, S Nagamori, Y Kanai, T Oyama and K Chikamatsu Br J Cancer 2014 110: 2506-2513; advance online publication, April 24, 2014; 10.1038/bjc.2014.178 Abstract | Full Text Tumour-initiating capacity is independent of epithelial–mesenchymal transition status in breast cancer cell lines G Xie, A Ji, Q Yuan, Z Jin, Y Yuan, C Ren, Z Guo, Q Yao, K Yang, X Lin and L Chen Br J Cancer 2014 110: 2514-2523; advance online publication, April 22, 2014; 10.1038/bjc.2014.153 Abstract | Full Text The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients S Krenn-Pilko, U Langsenlehner, E-M Thurner, T Stojakovic, M Pichler, A Gerger, K S Kapp and T Langsenlehner Br J Cancer 2014 110: 2524-2530; advance online publication, March 27, 2014; 10.1038/bjc.2014.163 Abstract | Full Text Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma O Dalpiaz, M Pichler, S Mannweiler, J M Martín Hernández, T Stojakovic, K Pummer, R Zigeuner and G C Hutterer Br J Cancer 2014 110: 2531-2536; advance online publication, April 1, 2014; 10.1038/bjc.2014.180 Abstract | Full Text Identification of high-risk patients with clear cell renal cell carcinoma based on interphase-FISH J Sanjmyatav, S Matthes, M Muehr, D Sava, M Sternal, H Wunderlich, M Gajda, M-O Grimm and K Junker Br J Cancer 2014 110: 2537-2543; advance online publication, March 25, 2014; 10.1038/bjc.2014.159 Abstract | Full Text Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study R S Croner, C-I Geppert, F G Bader, U Nitsche, C Späth, R Rosenberg, A Zettl, X Matias-Guiu, J Tarragona, U Güller, M Stürzl and M Zuber Br J Cancer 2014 110: 2544-2550; advance online publication, April 10, 2014; 10.1038/bjc.2014.170 Abstract | Full Text The intratumoural subsite and relation of CD8+ and FOXP3+ T lymphocytes in colorectal cancer provide important prognostic clues A Ling, S Edin, M L Wikberg, Å Öberg and R Palmqvist Br J Cancer 2014 110: 2551-2559; advance online publication, March 27, 2014; 10.1038/bjc.2014.161 Abstract | Full Text Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma S Han, C Zhang, Q Li, J Dong, Y Liu, Y Huang, T Jiang and A Wu Br J Cancer 2014 110: 2560-2568; advance online publication, April 1, 2014; 10.1038/bjc.2014.162 Abstract | Full Text Wild-type and mutant p53 differentially regulate NADPH oxidase 4 in TGF-β-mediated migration of human lung and breast epithelial cells H E Boudreau, B W Casterline, D J Burke and T L Leto Br J Cancer 2014 110: 2569-2582; advance online publication, April 8, 2014; 10.1038/bjc.2014.165 Abstract | Full Text The combination of strong expression of ZNF143 and high MIB-1 labelling index independently predicts shorter disease-specific survival in lung adenocarcinoma Y Kawatsu, S Kitada, H Uramoto, L Zhi, T Takeda, T Kimura, S Horie, F Tanaka, Y Sasaguri, H Izumi, K Kohno and S Yamada Br J Cancer 2014 110: 2583-2592; advance online publication, April 15, 2014; 10.1038/bjc.2014.202 Abstract | Full Text Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis J Yan, J De Melo, J-C Cutz, T Aziz and D Tang Br J Cancer 2014 110: 2593-2603; advance online publication, April 24, 2014; 10.1038/bjc.2014.201 Abstract | Full Text Hanging drop cultures of human testis and testis cancer samples: a model used to investigate activin treatment effects in a preserved niche A Jørgensen, J Young, J E Nielsen, U N Joensen, B G Toft, E Rajpert-De Meyts and K L Loveland Br J Cancer 2014 110: 2604-2614; advance online publication, April 29, 2014; 10.1038/bjc.2014.160 Abstract | Full Text Genetics and Genomics Top Erroneous identification of APOBEC3-edited chromosomal DNA in cancer genomics R Suspène, V Caval, M Henry, M S Bouzidi, S Wain-Hobson and J-P Vartanian Br J Cancer 2014 110: 2615-2622; advance online publication, April 1, 2014; 10.1038/bjc.2014.176 Abstract | Full Text Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US–UK study M P Little, M L Schaeffer, R C Reulen, D H Abramson, M Stovall, R Weathers, F de Vathaire, I Diallo, J M Seddon, M M Hawkins, M A Tucker and R A Kleinerman Br J Cancer 2014 110: 2623-2632; advance online publication, April 22, 2014; 10.1038/bjc.2014.193 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.